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Mouse  C  1300  neuroblastoma  (NB) 1 is a  tumor of sympathetic cells which 
grows  in  vitro  in  suspension  as  anaplastic  round  cells  (1).  When  clones  of 
these cells are plated on a  surface to which they can attach,  the cells differen- 
tiate  and  assume  many  of  the  morphological  and  biochemical  properties  of 
mature sympathetic cells (2). 
There has been intensive research to elucidate the electrophysiological, bio- 
chemical, and morphological characteristics of  these  cells, but  little attention 
has been paid so far to their surface membrane structure. 
While seeking specific sympathetic surface markers in  such  neoplastic cells, 
we  have  investigated  the  capacity  of  NB  to  bind  on  their  membrane,  the 
nerve growth factor (NGF), a  protein capable of inducing differentiation  and 
maintaining the life of sympathetic cells (3). This report describes some of the 
properties of  this  interaction  and  introduces preliminary data on  the  partial 
characterization of a  specific NGF  membrane  receptor site. 
Materials and Methods 
Protein and Chemicals.--Human  serum  albumin (HSA), horse spleen ferritin, and mouse 
and rabbit gamma globulins (MGG and RGG) were purchased from Mann Research Labs., 
Inc., New York; trypsin (bovine pancreas), from Worthington Biochemical Corp., Freehold, 
N. J.; fetal bovine serum (FBS) from Flow Laboratories, Inc., Rockville, Md.; trypticase soy 
broth (TSB) from Baltimore Biological Laboratories, Cockeysville, Md.; calf serum (CS) from 
Grand Island Biological Co.,  Grand Island, N.  Y.; ethylenediaminetetracetate-sodium salt 
(EDTA) and sodium-azide from Sigma Chemical Co., St. Louis, Mo.; and ammonium  sulfate 
from Merck Chemical Div., Merck & Co., Inc., Rahway, N. J. 
Source and Preparation of Cells.--The  following tumor cell lines were used: (a) a  mono- 
cloned mouse C 1300 NB from a line kindly supplied by Dr. Francois Jacob, Institut Pasteur, 
Paris, France. The cell line was maintained in tissue culture in Dulbeeco's modified Eagle's 
medium (DME) supplemented with 20% FBS in 12% C(h in air. Mter cloning in this labora- 
tory, the cells were homogeneous with respect to synchronization, morphology, staining charac- 
teristics, and sedimentation.  When transferred to serological petri dishes and grown in medium 
l Abbreviations used in this paper: CS,  calf serum;  DME,  Dulbecco's modified  Eagle's 
medium; FBS, fetal bovine serum.; K, relative average association  constant value; MEMG, 
MEM plus 0.4 mg of MGG; MGG, mouse gamma globulin; NB, neuroblastoma; NGF, nerve 
growth factor; NSR, NGF-specific  receptor-like molecule; RGG, rabbit gamma globulin. 
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lacking serum, most cells attached within 24 h and in 2-3 days sent out processes from the cell 
body, some of which were several millimeters long (2).  (b) Mouse L-929 cells were grown in 
minimum essential medium (MEM) supplemented with 10% CS and 10% TSB.  (c) Sarcoma 
S/180 cells were  obtained from  the American Type  Culture  Collection and  maintained in 
MEM supplemented with nonessential amino acids and 5% CS.  (d)  Sarcoma S/37 cells were 
obtained from Jackson Laboratories, Bar Harbor, Maine and carried for a  month by serial 
transplantation in female Swiss Webster mice  (Jackson Laboratories). The cells were  then 
established in our laboratory as a continuous cell line growing in suspension and named 2S/37. 
Other cells used were: sympathetic cells from ganglia of neonatal Swiss  Webster albino 
mice; spleen, kidney, and liver mouse cells freed of erythrocytes and nonviable cells by osmotic 
shock. For experiments all cells were washed three times in MEM without serum and main- 
tained in this medium with or without 0.005 M EDTA throughout the experiment. Cell viabil- 
ity was always over 90% as determined by 0.04% erythrosin dye exclusion. 
3 M  KCI extraction of NB Cdls.--The  procedure described by Reisfield et al. (4) has been 
performed.  2  )<  108 NB cells were suspended in 30 ml of phosphate-buffered saline (PBS) 
(0.05 M potassium phosphate and 0.15 M  NaC1),  pH 7.4, containing 3 M KC1 and stirred for 
16 h at 4°C.  Cells were then centrifuged at 1,500 g for 15 min and the supernate was recen- 
trifuged at 105,000 g for 120 min to remove gross aggregates and used just afterwards. 
NGF.--Mouse  salivary glands NGF was prepared by the method described by Bocchini 
and Angeletti (5). The highly purified protein, isolated as a 27,500 tool wt dimer, is composed 
of two identical polypeptide chains linked by noncovalent bonds (6). 1 mg of this protein dis- 
solved in 0.01 M potassium phosphate buffer has absorbancy of 1.680 at 280 nM OD readings. 
The biological activity of NGF was measured by the test of Levi-Montalcini (3);  10 ng of 
NGF induced differentiation in vitro of 14 day chick embryo sympathetic ganglia. 
Radioiodination  of Proteins.--The chloramine-T method described by Greenwood et al. (7) 
and modified slightly by Revoltella et al. (8) was used. Radioactivity measurements were done 
in a  LKB automatic spectrometer (Wallac Gamma Sampler Counter GTL, 300-500, LKB, 
Stockholm, Sweden) equipped with an NaI crystal. More than 95% of the radioiodinated pro- 
teins were precipitated by specific hyperimmune antibodies at equivalence. The counts pre- 
cipitated by a  known amount of ligand were considered as the "specific activity" of the 125I- 
labeled protein expressed as cpm/weight unit. Preparations ranging between 5  )<  105 to 106 
cpm//zg protein were generally used in experiments. Iodination did not alter the biological 
activity of the NGF. 
Binding  of [1251]Ligands to  Cells.--A  constant number of viable cells and increasing con- 
centration of 12SI-labeled ligand were incubated in duplicate at 2°C in 100 )< 7.5-mm disposable 
glass tubes. The ligand was diluted with MEM to which was added 0.4 mg MGG/ml (MEMG) 
to reduce nonspecific uptake by glass borosilicates. The final volume of the reaction mixture 
was 0.5 ml. Tubes containing the iodinated ligand and no cells were used as controls. Mter 
incubation for 30 min, tubes were centrifuged at 750 g for 5 min in a refrigerated International 
Centrifuge  (International Equipment  Co.,  Needham  Heights,  Mass.).  The  pellet was  re- 
suspended in 2.0 ml cold diluent, washed twice, and resuspended in 0.5 ml. An aliquot of this 
suspension was assayed for radioactivity. The counts in the controls were subtracted to deter- 
mine the value for specific binding by the cells.  From the specific activity of the [125I]ligand 
preparation, the uptake of radioactivity by the cells measured at saturation could be calcu- 
lated as follows: 
moles  of  [125I]ligand  bound  by  l0  s cells  =  cpm  at  the plateau  of  saturation 
specific activity (in cpm/mole) 
A  relative average association constant value (K)  was calculated from a  Scatchard plot of 
specific binding of [125I]NGF to cells, using the relationship (Bound)/(Free)  =  1/K(Binding 
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Binding of [t25I]NGF to Antibodies or Other Pro~eins.--The total NGF-binding capacity by 
antibodies or NGF specifically binding proteins was measured by a radioimmunoassay, follow- 
ing the procedure described by Revoltella et al. (8). In the standard assay, increasing concen- 
trations of [125I]NGF were incubated in glass tubes with 10 #g of the protein in test. After 2 h 
of incubation at room temperature, ammonium sulfate at a 37% final concentration was added 
to the reaction mixture. Tubes were centrifuged at 1,200 g for 30 rain and the pellet washed 
once. The last pellet was resuspended in 0.5 mi of 0.1 N  NaOH and 0.2  ml counted in the 
gamma  spectrometer.  By knowing  the  specific  activity of the  [125I]NGF preparation,  the 
moles of ligand bound by 10 #g of the substance in test was calculated from the counts at the 
plateau of saturation. 
Acrylamide Gel  Electrophoresis.--Electrophoresis of  proteins  dissolved  in  0.2%  sodium 
dodecyl sulphate (SDS) was performed on 7.5% acrylamide gel (6 x 80 ram, 3 mA/gel, pH 8.3 
at room temperature). Gels were stained with Coomassie Blue for quantitative determination 
of proteins. Radioactivity was assayed by autoradiography of dried gels. The molecular weight 
of NGF-binding protein(s) was determined by SDS gel electrophoresis, as described by Shapiro 
et al. (9). 
Amino Acids Analysis.--The  proteins were dissolved in 0.02  N  NaOH, adjusted  to 6 N 
HC1 with constant boiling HCI, and lyophilized for 24 h at 100°C in sealed evacuated tubes. 
Amino acid analysis was performed according to the method of Spackman et al. (10). 
RESULTS 
Binding of [125I]NGF to Cells.--The effect  of the concentration of [1251]NGF 
on the amount of ligand bound by the cells  was determined.  In addition, the 
binding  capacity of [1251]NGF was compared  to that of unrelated proteins 
such as RGG,  MGG,  and ferritin.  The number of moles of [ml]NGF  bound 
by NB  cells  at every ligand concentration was 20-30 times higher than the 
number of moles of the other ligands tested (Fig. I). 
Specificity of Binding of [~25I]NGF by NB.--In  order  to  determine  whether 
NGF  bound  preferentially  to  NB  cells,  binding  was  compared  in  a  series  of 
normal  and  tumor  cells  (Fig.  2).  The  ratios  of  [12~I]NGF  bound  by  NB  cells 
and by equal numbers of other cells were calculated at saturation  of the ligand- 
binding  capacity.  NB  cells  and  sympathetic  cells  showed  a  much  greater 
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FIG.  1.  Binding of different [12SI]ligands to a  constant number of C  1300 NB cells.  Mol 
wt of NGF and ferritin were taken, respectively, as 27,500 and 700,000;  of MGG and RGG, 
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Fro. 2.  Binding of [125I]NGF to cells. Similar number of C 1300 NB, L-929, 2S/37, S/180, 
and normal mouse sympathetic cells were incubated for 30 min at 2°C with increasing con- 
centrations of the ligand. Amount of cell-bound [1251]NGF was determined after two washes 
with 2 ml of MEMG. 
capacity for binding  [125I]NGF than other cells, even at low ligand concentra- 
tions. These differences were even more striking when corrections were made 
for differences  in  the  various  cells.  From  measurements of  the  diameters  of 
20-30 cells of each type, it was determined that NB cells (ca. 40 #m diameter) 
are intermediate  in size between L-929  and  2S/37  or S/180  (respectively 70, 
40, and 35 #m diameter) but are much larger than normal mouse spleen leuko- 
cytes,  or kidney  or liver cells,  which  are much more similar in  size  to  sym- 
pathetic cells.  If each cell is considered as a sphera and the amount of binding 
is  expressed  in  terms  of  the  amount  per  unit  area,  preferential  binding  by 
NB  or sympathetic cells was still  evident,  thus excluding the possibility that 
the differences can be explained on the basis of cell size. The binding of [125I]- 
NGF by increasing numbers of NB cells is shown in Fig. 3. Values of [I~I]NGF 
bound are expressed as specific binding by the cells,  i.e.  moles oi ligand bound 
to NB cells minus the average number of moles of ligand bound by equal num- 
bers of L-929,  2S/37,  and  S/180  control  cells.  The  average binding  of  [I~sI]- 
NGF by these latter cell controls was not significantly different from the num- 
ber of moles of the same ligand bound by the globulins in the medium diluent. 
As can be seen,  there  was  a  direct proportion  of binding  in  relation  to  cell 
number. 
Effect of Different Factors on the Binding of [12~I]NGF to Cells.--It was deter- 
mined  that saturation  of binding  occurred within  15  min and  a  standard  in- 
cubation time of 30 min was adopted. Repeated washing with MEMG removed 
only  about  50%  of  the  [~25I]NGF bound  to  NB  cells.  In  contrast,  washing 
removed  almost all  the  [~25I]NGF from control  cells  [Fig.  4).  The  effect was 
greatest with the first wash, whereas the next wash affected only the controls. 
Therefore, two washes were used in the standard  assay procedure. 
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FIO.  3.  Specific binding of [125I]NGF as a function of C 1300 NB-cell concentration. Bind- 
ing by L-929 cells was subtracted to yield values of specific binding. 
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FIG. 4.  Effect of washing on binding of  []25I]NGF.  Similar number of  C  1300  NB  and 
L-929, 2S/37,  or S/180 cells were incubated for 30 min at 2°C. The qu~,ntity of ligand re- 
maining bound to cells was measured after increasing washes with 2 ml of MEMG. 
and  L-929  cells  is  shown  in  Table  I.  A  significant  increase  in  binding  was 
shown by both types of cells, in particular  the control cells.  This may be ex- 
plained  by  increased  availability  after  fixation  of  low  avidity  binding  sites 
(11-13). 
Binding of NB cells was greatly reduced shortly after the cells were treated 
with  0.02 %  trypsin. However, binding  capacity was recovered and  after 3  h 
the  same  amount  of NGF  was  bound  as  before  treatment,  indicating  rapid 
replacement on the cell membrane of NGF-binding molecules. 
Divalent cations had no effect on binding reaction. When 2  X  105 NB cells 
were incubated  with  the ligand,  3.1  >(  10  -12 tool of [12~I]NGF were bound  at 
saturation.  In  the presence of 0.005  or 0.01  M  EDTA  the  same number  of 
cells bound 2.78  )<  10  -12 and 3.21  >(  10  -]2 tool of []25I]NGF,  respectively. 
Identity on Cell-Binding Capacity between Labeled and Unlabeled NGF.--When 442  RECEPTOR FOR  NERVE GROWTH FACTOR 
TABLE I 
Effect of Different Treatments on Binding of [1251]NGF by Calls at Saturation 
No  Trypsin* 
Cells  treatment  10 vain  60 min  180 min  Glutaraldehyde~: 
cpm  cpm  cpm  cpm  cpm 
C 1300 NB  32,518  1,214  18,318  35,141  275,418 
L-929  1,321  818  1,312  1,280  25,421 
* 2 ×  107 ceils were incubated  for 10 min at 37°C with  0.02% trypsin.  Cells were washed 
three times and then incubated after 10, 60, and 180 min with [125I]NGF  at 2°C. Cell viability 
was higher than 85-90%. 
2 X  107 cells were incubated  in 1% glutaraldehyde  in MEM for 10 min and then thor- 
oughly washed with medium supplemented with 0.02 M glycine. 
a  decreasing  number  of NB  cells  was  incubated  with  a  constant  amount  of 
[125I]NGF,  binding curves such as the upper one in Fig. 5  were obtained.  The 
sigmoid  curve  leads  to  two  plateaus,  the  upper  representing  a  condition  of 
complete saturation of the [~SI]NGF by excess-binding sites,  the lower indicat- 
ing an excess of ligand as compared to available  receptor sites.  When unlabeled 
and 125I-labeled  NGF were added together to the reaction tubes before adding 
cells,  modifications  of the  binding  curve  occurred,  indicating  that  unlabeled 
NGF competitively bound to cells and prevented fixation of [~SI]NGF to some 
cell  receptors.  The  binding  capacity  at  different  cell  concentrations  of NGF 
of the four different resulting specific activities,  was then analyzed by plotting 
values in terms of the reciprocal of bound vs. the  reciprocal of free  [~25I]NGF 
(8).  At a  cell concentration corresponding to about 30%  of the  maximal  cell- 
binding capacity for [125I]NGF  (8)K  104 cells)  a  straight line can be drawn,  as 
shown in the inset of Fig. 5. Curves bent  towards the  ordinate or the  abscissa 
were drawn, respectively, at smaller or higher cell concentrations. The straight 
line  therefore  represents  a  situation  of equilibrium  between  different  avidity 
receptor sites  (8). The intercept in the ordinate of this straight  line represents 
the  reciprocal  value  of  the  total  [~2~I]NGF  moles  bound  by  that  number  of 
cells.  This  value  closely corresponds  to  the  same  concentration  of  [125I]NGF 
bound, which can be calculated at saturation from a  radioimmunoassay on the 
same cells. This shows that even if there  is heterogeneity  of binding  capacity 
by the cells,  there is identity between labeled  and unlabeled NGF. 
K  and  Number  of Binding  Sites  per Cell.--K  for  the  [12~I]NGF  interaction 
with  NB  cells  was  calculated  from  a  curve  of  specific  binding  at  different 
ligand  concentrations,  up  to  a  plateau  of saturation  (Fig.  6),  using  the  rela- 
tionship  (Bound)/(Free)  =  1/K  (Binding  sites)  --  (Bound)  (14).  In several 
independent  experiments  the values for K  ranged between  0.8 and  5.6  )<  107 
liters/mol.  10 ° NB cells bound on an average 6  )<  10  -~2 mol of [125I]NGF  (Fig. 
6).  By the Avogadro number,  this  figure  corresponds  to  about  106 molecules 
of  [125I]NGF  bound/cell.  NGF  is,  however,  a  multivalent  ligand  and  each R.  REVOLTELLA~  L.  BERTOLINI,  M.  PEDICONI~  E.  VIGNETI  443 
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F[o. 5.  Inhibition of [125I]NGF uptake by unlabeled NGF. 2.5  X  10  -12 moles of [t~6I]NGF 
(sp act,  160,000 cpm/10  -12 mol) were added to all tubes.  /X--/x,  no unlabeled NGF added; 
I-q--I-l,  0.8 X  10  -12 mol of unlabeled NGF added; ~--~,  2.5 X  10  -12 mol of unlabeled NGF 
added; and  O--O,  7.5  >(  10  -12 mol of  unlabeled  NGF  added. The  Sips plot of data  at a 
cell concentration  of 8  )<  104 allowed the calculation of the total NGF-binding capacity by 
cells which were  1.31  X  10  -12 mol. By a direct immunoassay performed on cells of the same 
source,  the recovery was 1.8  X  10  -12 mol of NGF bound/8  X  104 cells. 
molecule could independently interact with more than one receptor site on the 
cell surface. It is therefore arbitrary to calculate an exact number of binding 
sites from this data. Only a minimum value can be calculated with the assump- 
tion that the number of binding sites  available on  the cell surface is  equal to 
or greater than the number of [125I]NGF molecules bound. 
Preliminary experiments suggested  that  exposure of NGF-binding sites on 
the NB-cell membrane might vary with  the cell cycle and  therefore binding 
experiments were done on synchronized cells. NB synchronization was achieved 
by culturing  the cells for 48 h  in DME  lacking isoleucin at pH 6.5  (15-16). 
Maximal exposure of binding sites for NGF occurred during a restricted phase 
of  the  cycle  which  preceeds  DNA  synthesis  ([SH]thymidine  incorporation) 
(Table II). At the same time,  the K  value of the interaction changed during 
different stages  of the cell cycle, with maximal  values obtained at stages of 
maximal NGF-binding capacity. 
Displacement of Bound [125I]NGF by Unlabeled NGF, In Relation to NB Growtk 
Cycle.--Increasing  concentrations of unlabeled NGF  (from 10  -3 to 10  +2 #g of 
protein) were added to tubes containing 5  X  105 cells and 0.05 ~g protein of 444  RECEPTOR  FOR NERVE  GROWTH  FACTOR 
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Fro. 6. Binding as a function of concentration  of [125I]NGF, and Scatchard  plot of these 
data. On the Scatchard plot, the slope is equivalent to 1/K. 
TABLE II 
Binding of [nSI]NGF by Synchronized C 1300 NB Cells During a Growth Cycle 
[SH]Thyrnidine  [z s6I]NGF bound/10 6 
Time  uptake*  cells~;  K 
h  cpm/lO 6  cells  moles  X  10 -12  10 v  liters~real 
0  300  34.00  4.60 
2  370  42.00  6.20 
4  1,105  1.00  2.00 
6  14,026  0.02  0.80 
8  4,378  0.08  0.93 
10  1,712  0.10  1.31 
12  419  0.70  2.56 
* [aH]Thymidine sp act 5 Ci/mmol, dosage 0.5 #Ci/ml, pulse time 1 h. 
:~ [t25I]NGF, sp act 1.7 X  106 epm/#g protein. 
intensively iodinated NGF  (sp act 1.5  X  106 cpm/~g). The number of counts 
bound  decreased  proportionately.  When  NB  cells  synchronized  in  the  Gx 
phase were used, complete displacement of labeled NGF required 50 #g protein 
of unlabeled  NGF,  whereas  with  cells  in  the  late  S  phase,  this  required  only 
0.4 ~g of protein  (Fig. 7). 
Partial Characterization  of NGF-Specific Receptor  (NSR).--When  [I~I]NGF 
was  added  dropwise  at  37°C  to  the  105,000  g  supernate  obtained  after  3  M 
KCI extraction of NB cells, precipitate  appeared  almost instantly.  This  pellet 
was washed three  times and dissolved in SDS. Acrylamide  gel  electrophoresis 
showed that  after removal of the pellet  the supernate  was lacking one major 
protein  component,  representing  about  2-5 %  of the  total  extracted  proteins. R.  REVOLTELLA~  L.  BERTOLINI~  M.  PEDICONI,  E.  VIGN'ETI  445 
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FIG. 7.  Displacement of binding of 0.05 ~g of [125I]NGF from 5 N  105 C 1300 NB cells, 
by increasing concentrations of unlabeled NGF, is considered as 100%. Cells were synchro- 
nized in the G1 phase (A--A) or in the late S phase (/x--A) of the growth cycle. 
(Fig.  8). Molecular weight determinations on SDS acrylamide gels, show that 
the  purified  material  (NGF-specific-receptor-like molecule,  tentatively  called 
NSR) has a tool wt of about 52,000. The amino acid composition of NSR ob- 
tained from the gel band (Table III) indicates a  rather high concentration of 
aspartic and glutamic acids, a  composition very similar to that obtained with 
tubulin proteins (17). Very similar results from different purified NSR prepara- 
tions were obtained,  yielding almost identical amino acid patterns,  suggesting 
high purity and  specificity of the  material.  Large amounts of NSR could be 
isolated  after  paper  electrophoresis.  The  direct  interaction  between  highly 
purified  NSR  and  [~25I]NGF was  then  measured  by a  radioimmunoassay  at 
2°C.  At  this  low  temperature,  before  adding  the  ammonium sulfate  salt,  no 
spontaneous  precipitate  was  obtained,  at  least  after  a  few  hours  from  the 
moment of the interaction of the reagents. In the radioimmunoassay, a satura- 
ble-binding  curve  was  obtained,  the  process  following  Michaelis-Menten 
kinetics.  From  a  Scatchard  plot  of  the  data  of  specific  binding  (e.g.,  total 
binding subtracted from the nonspecific binding due to the diluent)  K  in  the 
range of 107 literes/mol was obtained. 
Inhibition of NGF Binding by NB Cells Incubated  "with  A nti-NSR A ntibody.-- 
NB cells were suspended  in  DME  and  incubated  with  heat-decomplemented 
rabbit antibodies prepared against highly purified NSR.  As controls, cells were 
incubated  with  rabbit  antiferritin  antibodies  or  normal  RGG,  all  diluted  to 
the  same final protein  concentration.  Each of the  globulin fractions was first 
absorbed  at  4°C  for  16  h  with  a  suspension  of kidney  cells  from A/J  mice, 
the same strain from which  the C  1300  NB  cells originated. After incubation 
with antibody, cells were washed twice and exposed  to [125I]NGF. The binding 
capacity  of  106  cells  incubated  with  normal  gamma globulin  or  antiferritin 
antibodies was 5.72  X  10  -12 and 6.18  >(  10  -12 mol of [12~I]NGF, respectively. 446  RECEPTOR  FOR  NERVE  GROWTH  FACTOR 
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FIG. 8.  Electrophoretic patterns of NB proteins extracted by 3 M  KCI and incubated in 
vitro with NGF. Densitometer tracing of: (A), total soluble cell extract and NGF; (B), pellet 
obtained by centrifugation at 105,000  g for 1 h, after incubation at 37°C for 60 min in the 
presence of  10  -3 mM  MgCl2; and  (C), supernate obtained after the above reaction. Arrow 
indicates the position of the protein specifically binding NGF (NSR). 
Anti-NSR  antibodies  reduced  the  binding  capacity to  less  than  6.2  X  10  -14 
tool/106 cells. 
Cytotoxic  E~ect of Anti-NSR Antibodies on NB Cells.--A specific cytotoxic 
effect of rabbit anti-NSR or antipurified rat  brain tubulin  antibodies  was ob- 
tained  when  NB  cells were incubated  at 37°C  for 60  min in  the presence of 
complement (guinea pig serum diluted  I/i  ). Antiferritin antibodies and normal 
gamma globulins were not cytotoxic, at the same protein concentrations (Table 
IV). When  synchronized cells were used,  the cytotoxic effect after incubation 
at 37°C for 30 rain  was  much more pronounced  in cells at a phase of the cell 
cycle immediately preceeding DNA synthesis (Table  IV). 
DISCUSSION 
The evidence presented  in  these  experiments clearly indicates  that  murine 
C  1300 NB and normal sympathetic cells bind NGF  in vitro, at 2°C, on their R.  REVOLTELLA~  L.  BERTOLINI,  M.  PEDICONI,  E.  VIGNETI  447 
TABLE III 
Amino Acid Composition of (NGF) Binding Protein(s) 
Amino acid  Tubulin* 
NGF-precipitated proteins 
Mouse  C 1300 NB 
brain extract  extract 
mole percentage 
Lysine  6.51  6.1  6.21 
Histidine  2.74  2.0  2.35 
Arginine  5.62  5.2  5.74 
Aspartic acid  10.24  10.0  10.51 
ThreonineJ~  6.41  6.5  6.18 
Serine~  5.62  7.0  5.54 
Glutamic acid  13.18  13.0  13.41 
Proline  5.02  5.1  5.04 
Glycine  8.14  --  8.18 
Alanine  8.08  8.7  7.64 
Half cystine  1.68  --  1.61 
Valine  6.51  6.8  6.24 
Methionine  2.74  --  3.18 
Isoleucine  4.98  4.4  4.81 
Leucine  8.50  7.15  7.52 
Tyrosine  3.02  --  3.38 
Phenylalanine  4.12  3.8  4.34 
Mole percentage for tubulins. Average of duplicate sets of 24-h hydrolysis. 
* Purified tubulin prepared as described  by Shelanski et al. (28). The NGF-precipitated 
proteins were obtained by addition of NGF at 37°C to a 105,000 g supernate of mouse brain 
homogenate  prepared as described  in the test. The NGF-precipitated proteins from murine 
C  1300 NB proteins were  obtained by addition of NGF to a  105,000 g supernate of 3 M 
KCI extract, prepared as described by Reisfield et al. (4). 
Threonine and serine were determined by extrapolation to zero hydrolysis time. 
membrane surface. These results are in line with recent observations by Baner- 
jee et al.  (18)  on human  sympathetic cells. The results of the  experiments can 
be  summarized  as follows:  (a)  the  binding  of  [I~SI]NGF is  not  mediated  by 
divalent cations, since 0.01  M  EDTA  had no inhibitory effect; (b)  the binding 
is not dependent on the cell metabolic  activity, as  indicated by  the fact  that 
it takes place at 2°C or in presence of Na-azide, or after cell fixation in glutar- 
aldehyde;  (c)  the  receptor for NGF binding is most likely of a protein nature, 
as suggested by  the  fact  that  trypsin  abolished  the  binding  capacity by  the 
cells, however  the  binding  reappears  within  1-2  h,  suggesting  that  such  re- 
ceptors might  play a  significant  role  in  the  cell membrane  function;  (d)  the 
binding is  specific for NGF  in view  of  the  fact  that  it  can  be  inhibited  by 
unlabeled NGF. In addition, NB  cells exhibited  a  [12~I]NGF-binding capacity 
several times higher than  the binding exhibited by a  variety of other  ligands 
tested (Fig. 1). As can be seen in the figure, at saturation of binding capacity, 
106 NB  cells bound about 6  X  10  --12 tool of [125I]NGF, a  value which is 70-80 448  RECEPTOR FOR  NERVE GROWTH FACTOR 
TABLE IV 
Cytotoxic Effect of Rabbit Antibodies on Synchronized Murine C 1300 NB Cells In  Vitro* 
Cytotoxic effects 
Antibodies§  Time  [3H]Thymidine  Normal§  uptake~  aroma  Antirat 
g~'obulins  Antiferritin  Anti-NSR  brain 
tubulin 
h  cpm/lO  6 cells  % vmbilily 
0  254  95  97  25  24 
3  318  91  91  12  5 
6  18,217  92  93  51  62 
9  2,351  91  92  64  71 
12  541  92  94  71  74 
15  618  94  95  70  78 
* Cells were incubated for 60 min at 37°C, in presence  of added complement (guinea pig 
serum diluted  1/5),  with normal RGG or different  types of antibodies. Viability of cells 
was scored by 0.04~ erythrosin dye exclusion. 
~t [SH]thymidine, sp act, 5 Ci/mM; dosage, 0.5 uCi/ml; pulse time, 1 h. 
§ Globulin fractions obtained from  sera precipitated at 35% ammonium  sulfate satura- 
tiou. Sera had been previously absorbed at 4°C for 16 h with a suspension  of kidney cells 
from  A/J mice.  Rabbit anti-NSR and antirat brain tubulin antibodies had, respectively, 
42 ~g and 38 ug antibody protein/ml as determined by a quantitative precipitin test using 
purified tubulin as antigen. All globulins were diluted to the same final protein concentration 
before exposure to cells. 
times  higher  than  the  average  binding  capacity  exhibited  for  other  tested 
ligands.  Moreover,  the binding  capacity exhibited at  saturation  by NB  cells 
or sympathetic mouse cells (Fig. 2) was 40-70 times higher than  that  shown  by 
an equal number of other tumor or normal cells. Such a preferential expression 
of  sites  capable  of  specifically binding  the  NGF  molecule probably justifies 
the  in  vitro  and  in  vivo well-documented unique  responsiveness to  N GF by 
these target cells (3).  From our data it would result that  about  105-106 mole- 
cules of [~25I]NGF  can be bound at saturation by a  single NB cell in suspension 
at  2°C,  exhibiting a  K  in  the  range of  107  liters/mol. This number  of bound 
molecules may be even higher, since indentation, folding, and refolding of the 
cell  membrane  may  mask  receptor  sites.  This  number  fluctuates,  however, 
during the different phases of the cell cycle and  so does the average value of 
the relative association constant of their interaction. 
This phenomenon  was  already described in previous reports,  using  a  tech- 
nique of rosette formation by NB  cells incubated at 2°C for a  short period of 
time, with sheep erythrocytes passively coated with NGF.  2 In agreement with 
these preliminary observations, the results presented in Table II indicate that 
2 Revoltella, R., C. Bosman, and L. Bertolini.  1974. Nerve growth factor binding sites in 
synchronized  murine C 1300 neuroblastoma-rosette forming cells. Specificity and morphology 
of rosette formation.  Cancer  Res. Manuscript submitted for publication. R.  REVOLTELLA,  L.  BERTOLINI,  M.  PEDICONI,  E.  VIGNETI  449 
the binding capacity by NB cells was maximal during the late G1 and early S 
phase. Displacement experiments reported in Fig.  7 gave additional confirma- 
tion to  these findings,  indicating different requirements of cold NGF  to dis- 
place  a  certain amount of labeled NGF from the membrane surface of syn- 
chronized NB cells,  at different phases of their cycle. These findings may be 
justified in view either of a possible different expression of receptor molecules. 
onto the membranes, or to rearrangements of these molecules, in relation to the 
physiological requirements of the cell during the different phases of the  cycle. 
In both cases a variation in cell-binding capacity occurs. Restricted expres- 
sion  of receptors during  the  cell cycle has  been  also  demonstrated  in  many 
different systems, in bacteria (19)  or mammalian  cells  (20-22),  and probably 
represents a critical step in the life controlling their further proliferation and/or 
differentiation (23);  (e)  the  question  is  now  raised  as  to  the  nature  of  this 
NGF-specific-binding protein. Preliminary experiments have been performed 
with  the  aim of isolating from the  NGF  target cells such  molecules. A  pro- 
tein(s), of about 52,000 mol wt (exhibiting a K  with NGF of about 107 liters/ 
mol), could be isolated from the supernate of NB cells after their exposure for 
several hours, in the cold, to 3  M  KC1.  The amino  acid composition of such 
purified NGF specifically binding material  (Table IID  revealed a  remarkable 
similarity with  a protein which is  known to be a  fundamental  component of 
microtubules, named tubulin (17). The idea of considering tubulin as a possible 
receptor for NGF was supported by recent investigations in our laboratory by 
Calissano  et  al.  (24)  who  showed  that  purified rat  brain  tubulin  exhibits in 
vitro a  K  of binding for monomeric NGF in the range of 106-107 liters/mole. 
A  possible  identity ot  the  protein responsible for NGF binding  to  its  target 
cell and tubulin came also from experiments performed with antibodies against 
NSR or a purified preparation of tubulin obtained from rat brains. These ex- 
periments showed that  these  antibodies,  when added  to a  suspension of NB 
cells,  inhibited the binding of NGF to the cell  membrane. In the presence of 
the  complement these  antibodies produced a  specific cytotoxic effect on  the 
target cells which was maximal in correspondence to the GI phase of the cycle, 
at  their  NGF  higher-binding  capacity.  Antibodies  made  against  ferritin  or 
normal gamma globulin had no effect (Table IV). 
It is also known that microtubule proteins are rather obiquitous in all cellu- 
lar systems so far investigated, and chemically or immunologically almost in- 
distinguishable (25). It is tempting to correlate the similarity of these findings 
with  the  possibility  that  insoluble  microtubule  proteins,  exposed  onto  the 
membrane of NB  or sympathetic cells,  might by themselves act  as  a  source 
of receptor sites for NGF. At variance with this hypothesis, these microtubule 
proteins  might  cooperate  with  membrane  tightly  associated  specific  NGF 
receptors, undergoing polymerization and tubule formation after the  receptors 
interaction  with  NGF  molecules,  as  suggested  in  a  different  experimental 
model by Edelman  et  al.  (26).  In normal sympathetic cells,  such  a  reaction 
probably might represent the initial step of neuron differentiation (27). 450  RECEPTOR FOR  NERVE GROWTH FACTOR 
SLrM.MARY 
Murine  C  1300  neuroblastoma cells bind with  high  avidity on  their mem- 
brane surface the nerve growth factor (NGF),  a  protein  capable of inducing 
differentiation of sympathetic nerve cells.  The total binding  capacity  of NGF 
by the  cells was quantitatively  measured by a  radioimmunoassay technique, 
using  ~25I-labeled NGF.  An  average number of about  106 molecules of NGF 
could be bound,  at saturation,  by each cell with  an average relative associa- 
tion constant of about  107 liters/tool.  Using synchronized cells, it was found, 
however, that either the number of molecules of ligand bound or the avidity 
of the binding interaction between NGF and cells varied depending upon their 
growth cycle, the maximal-binding occurring during the G1 and early S phase. 
Binding  of [t2q]NGF  was suppressed by trypsin  treatment of the  cells,  how- 
ever  new  receptor  sites  were  rapidly  replaced  onto  the  membrane  surface 
within  1-2 h.  Cells exposed to 3 •  KCI released into  the supernate  a  protein 
product exhibiting similar high avidity for NGF. Acrylamide gel electrophore- 
sis  suggested  a  restricted  molecular  heterogeneity  of  this  product,  with  a 
major component in the 52,000 tool wt region. Antibodies made specific to this 
protein  were  capable,  in  the  absence  of  the  complement,  of  inhibiting  the 
binding of [I~q]NGF by the cells and in the presence of the complement they 
killed them. 
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